Oncogene-induced senescence as an initial barrier in lymphoma development
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Acute induction of oncogenic Ras provokes cellular senescence involving the retinoblastoma (Rb) pathway, but the tumour suppressive potential of senescence in vivo remains elusive. Recently, Rb-mediated silencing of growth-promoting genes by heterochromatin formation associated with methylation of histone H3 lysine 9 (H3K9me) was identified as a critical feature of cellular senescence, which may depend on the histone methyltransferase Suv39h1. Here we show that Emicro-N-Ras transgenic mice harbouring targeted heterozygous lesions at the Suv39h1, or the p53 locus for comparison, succumb to invasive T-cell lymphomas that lack expression of Suv39h1 or p53, respectively. By contrast, most N-Ras-transgenic wild-type ('control') animals develop a non-lymphoid neoplasia significantly later. Proliferation of primary lymphocytes is directly stalled by a Suv39h1-dependent, H3K9me-related senescent growth arrest in response to oncogenic Ras, thereby cancelling lymphomagenesis at an initial step. Suv39h1-deficient lymphoma cells grow rapidly but, unlike p53-deficient cells, remain highly susceptible to adriamycin-induced apoptosis. In contrast, only control, but not Suv39h1-deficient or p53-deficient, lymphomas senesce after drug therapy when apoptosis is blocked. These results identify H3K9me-mediated senescence as a novel Suv39h1-dependent tumour suppressor mechanism whose inactivation permits the formation of aggressive but apoptosis-competent lymphomas in response to oncogenic Ras.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [120]
In the citing paper
“Oncogene-induced senescence protects against tumor initiation 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [36]
In the citing paper
“OIS is a powerful tumor suppressor mechanism 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [36]
In the citing paper
“a series of studies [22][23][24][25][26] identified senescence in several premalignant tumours, both in humans and mice.”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [22]
In the citing paper
“| DNA damage | Eμ-Nras G12V ; ectopic Bcl2 | Doxorubicin | Lymphoma regression | 22 | | | |”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [22]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978 · cited 1×
“5 with a T(6;15) translocation (see Supplementary Table 3 for details).”
BackgroundSelective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
Self-citationRegulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 1×
“5 with a T(6;15) translocation (see Supplementary Table 3 for details).”
BackgroundSelf-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
Self-citationSibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Self-citation
Cited by
Items 801–900 of 1,001
Yoshizuka, N., Lai, M., Liao, R., Cook, R., Xiao, C., Han, J., & Sun, P. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0576 · Cited by 18
Alectinib for Treatment of ALK -Positive Non-Small-Cell Lung Cancer
Avrillon, V., & Pérol, M. (2016) · Future Oncology · doi:10.2217/fon-2016-0386 · Cited by 18
A High Glycolytic Flux Supports the Proliferative Potential of Murine Embryonic Stem Cells
Kondoh, H., LLeonart, M. E., Nakashima, Y., Yokode, M., Tanaka, M., Bernard, D., Gil, J., & Beach, D. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.ft-14 · Cited by 19
The Yin-Yang of DNA Damage Response: Roles in Tumorigenesis and Cellular Senescence
Li, X., Xu, H., Chong-an, X., Lin, M., Song, X., Yi, F., Feng, Y., Coughlan, K. A., Cho, W., Kim, S. W., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022431 · Cited by 20
Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions
Saleh, T., & Carpenter, V. J. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000361 · Cited by 17
Wuestefeld, A., Iakovleva, V., Yap, S. X. L., Ong, A. B. L., Huang, D. Q., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., Zender, L., & Wüestefeld, T. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1477 · Cited by 18
Aging and oral squamous cell carcinoma development: the role of cellular senescence
Niklander, S. E., Aránguiz, P., Faunes, F., & Flores, R. (2023) · Frontiers in Oral Health · doi:10.3389/froh.2023.1285276 · Cited by 20
Chiba, M., Miyata, K., Okawa, H., Tanaka, Y., Ueda, K., Seimiya, H., & Takahashi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216399 · Cited by 17
The Regulation of Cellular Senescence in Cancer
Zhang, X., Gao, Y., Zhang, S., Wang, Y., Du, Y., Hao, S., & Ni, T. (2025) · Biomolecules · doi:10.3390/biom15030448 · Cited by 17
Li, H., Zhang, W., Zhao, K., Zhao, D. H., Zheng, S., & Hu, Y. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011411 · Cited by 18
Heterogeneity of DNA damage incidence and repair in different chromatin contexts
Ortega, P., Gómez‐González, B., & Aguilera, A. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103210 · Cited by 19
Chromatin: a molecular interface between cancer and aging
Cruickshanks, H. A., & Adams, P. D. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.007 · Cited by 17
Cancer as a disease of tissue pattern formation
Marongiu, F., Doratiotto, S., Sini, M., Serra, M. P., & Laconi, E. (2012) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2012.08.001 · Cited by 23
Raouf, S., Weston, C. R., Yucel, N. D., & Reproducibility Project: Cancer Biology (2015) · eLife · doi:10.7554/elife.04105 · Cited by 17
Åman, P., Dolatabadi, S., Švec, D., Jonasson, E., Safavi, S., Andersson, D., Grundevik, P., Thomsen, C., & Ståhlberg, A. (2016) · The Journal of Pathology · doi:10.1002/path.4700 · Cited by 23
Michaloglou, C., Soengas, M. S., Mooi, W. J., & Peeper, D. S. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701221 · Cited by 24
Failure of immunosurveillance accelerates aging
Pérez-Lanzón, M., Zitvogel, L., & Kroemer, G. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1575117 · Cited by 17
Dehghan, N., Mousavikia, S. N., Qasempour, Y., & Azimian, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123218 · Cited by 16
Increased chromatin accessibility underpins senescence
Lopes‐Paciencia, S., & Ferbeyre, G. (2025) · FEBS Journal · doi:10.1111/febs.70136 · Cited by 18
INK4a/ARF limits the expansion of cells suffering from replication stress
Monasor, A., Murga, M., Lopez-Contreras, A. J., Navas, C., Goméz-López, G., Pisano, D. G., & Fernández-Capetillo, Ó. (2013) · Cell Cycle · doi:10.4161/cc.25017 · Cited by 18
Han, Y., Micklem, G., & Kim, S. Y. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101849 · Cited by 19
Recent Advances in Senolysis for Age-Related Diseases
Aratani, S., & Nakanishi, M. (2023) · Physiology · doi:10.1152/physiol.00003.2023 · Cited by 19
Ceteci, F., Xu, J., Ceteci, S., Zanucco, E., Thakur, C., & Rapp, U. R. (2011) · Neoplasia · doi:10.1593/neo.11652 · Cited by 17
A Genetic Screen Identifies Topoisomerase 1 as a Regulator of Senescence
Humbert, N., Martien, S., Augert, A., Costa, M. D., Mauën, S., Abbadie, C., de Launoit, Y., Gil, J., & Bernard, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2864 · Cited by 16
McGowan, E. M., Tran, N., Alling, N., Yagoub, D., Sedger, L. M., & Martiniello‐Wilks, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042246 · Cited by 17
Molecular mechanisms of cellular senescence and immortalization of human cells
Kiyono, T. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.12.1623 · Cited by 19
Role of p38 MAPK pathway in BMP4-mediated Smad-dependent premature senescence in lung cancer cells
Su, D., Xiu-E, P. E. N. G., Zhu, S., Huang, Y., Dong, Z., Zhang, Y., Zhang, J., Liang, Q. Y., Lü, J., & Huang, B. (2010) · Biochemical Journal · doi:10.1042/bj20100404 · Cited by 16
Biliary Epithelial Apoptosis, Autophagy, and Senescence in Primary Biliary Cirrhosis
Sasaki, M., & Nakanuma, Y. (2010) · Hepatitis Research and Treatment · doi:10.1155/2010/205128 · Cited by 17
Sayers, C. M., Papandreou, I., Guttmann, D. M., Maas, N. L., Diehl, J. A., Witze, E. S., Koong, A. C., & Koumenis, C. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081810 · Cited by 16
Balancing Between Aging and Cancer: Molecular Genetics Meets Traditional Chinese Medicine
Liu, J., Peng, L., Huang, W., Li, Z., Pan, J. P., Sang, L., Lu, S.-Q., Zhang, J., Li, W., & Luo, Y. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25898 · Cited by 17
Kamijo, H., Sugaya, M., Takahashi, N., Oka, T., Miyagaki, T., Asano, Y., & Sato, S. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-017-1749-9 · Cited by 16
Aberrant signaling and senescence associated protein degradation
Ferbeyre, G. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.016 · Cited by 16
Walen, K. H. (2011) · Journal of Cancer Therapy · doi:10.4236/jct.2011.22023 · Cited by 16
Zhang, L., Wu, R., Dingle, R. W. C., Gairola, C. G., Valentino, J. P., & Swanson, H. I. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.08.008 · Cited by 16
Choi, O. R., Ryu, M. S., & Lim, I. K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.05.014 · Cited by 18
Montuori, G., Tu, F., Qin, D., Schmargon, R., Rodriguez-Fos, E., Helmsauer, K., Hui, H., Mandal, S., Purshouse, K., Fankhänel, L., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-1738 · Cited by 15
Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control
Belenki, D., Richter‐Pechańska, P., Shao, Z., Bhattacharya, A., Lau, A., de Freitas, J. A. N. L. F., Kandler, G., Hick, T., Cai, X., Scharnagl, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57429-x · Cited by 16
Self-citationMaintaining Low BCR-ABL Signaling Output to Restrict CML Progression and Enable Persistence
Burchert, A. (2014) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-013-0196-8 · Cited by 17
Stem Cell Senescence: the Obstacle of the Treatment of Degenerative Disk Disease
Chen, Y., & Tang, L. (2019) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x14666190906163253 · Cited by 16
Possibility of inducing tumor cell senescence during therapy (Review)
Wang, G., Cheng, X., Zhang, J., Liao, Y., Jia, Y., & Qing, C. (2021) · Oncology Letters · doi:10.3892/ol.2021.12757 · Cited by 19
Cai, D., Zhao, Z., Hu, J., Dai, X., Zhong, G., Gong, J., & Qi, F. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.836080 · Cited by 17
The Effect of GADD45a on Furazolidone‐Induced S‐Phase Cell‐Cycle Arrest in Human Hepatoma G2 Cells
Sun, Y. N., Tang, S., & Xiao, X. (2015) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21719 · Cited by 16
Sinha, V. C., Qin, L. F., & Li, Y. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0481-t · Cited by 18
Cellular Senescence: Many Roads, One Final Destination
Saab, R. H. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.68 · Cited by 16
Francica, P., Aebersold, D. M., & Medová, M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.08.022 · Cited by 16
Zhang, Y., Gu, M., Zhou, X., Ma, H., Yao, H., & Ji, F. (2014) · Oncology Reports · doi:10.3892/or.2014.3281 · Cited by 15
Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma
Liu, X., Xie, W., Meng, S., Kang, X., Liu, Y., Guo, L., & Wang, C. (2022) · Cells · doi:10.3390/cells11172654 · Cited by 18
The Potent and Paradoxical Biology of Cellular Senescence in Cancer
Romesser, P. B., & Lowe, S. W. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-124434 · Cited by 16
Joaquin, A., & Fernández-Capetillo, Ó. (2012) · InTech eBooks · doi:10.5772/50863 · Cited by 16
Epigenetic Dysregulation Induces Translocation of Histone H3 into Cytoplasm
Wang, Z., Chen, J., Gao, C., Xiao, Q., Wang, X., Tang, S., Li, Q., Zhong, B., Song, Z., Shu, H., et al. (2021) · Advanced Science · doi:10.1002/advs.202100779 · Cited by 18
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Gazzillo, A., Volponi, C., Soldani, C., Polidoro, M. A., Franceschini, B., Lleò, A., Bonavita, E., & Donadon, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010026 · Cited by 15
Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue
Brondello, J., Philipot, D., Djouad, F., Jørgensen, C., & Noël, D. (2010) · The Open Rheumatology Journal · doi:10.2174/1874312901004010010 · Cited by 15
Acute MUS81 depletion leads to replication fork slowing and a constitutive DNA damage response
Xing, M., Wang, X., Palmai‐Pallag, T., Shen, H., Helleday, T., Hickson, I. D., & Ying, S. (2015) · Oncotarget · doi:10.18632/oncotarget.5497 · Cited by 15
Bose, S., Sakhuja, P., Bezawada, L., Agarwal, A., Kazim, S. N., Khan, L. A., Sarin, S. K., & Ramakrishna, G. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06305.x · Cited by 14
Human skin neural crest progenitor cells are susceptible to BRAFV600E-induced transformation
Kumar, S., Dai, J., Li, S., Yang, R., Yu, H., Nathanson, K. L., Liu, S., Zhou, H., Guo, J., & Xu, X. (2013) · Oncogene · doi:10.1038/onc.2012.642 · Cited by 17
Assessing PCR Inhibition from Humic Substances
Matheson, C., Gurney, C., Esau, N., & Lehto, R. (2014) · The Open Enzyme Inhibition Journal · doi:10.2174/1874940201003010046 · Cited by 17
Cell Senescence in Myxoid/Round Cell Liposarcoma
Gustafsson, C. K., Ståhlberg, A., Engtröm, K., Danielsson, A., Turesson, I., & Åman, P. (2014) · Sarcoma · doi:10.1155/2014/208786 · Cited by 15
Detecting Markers of Therapy-Induced Senescence in Cancer Cells
Fan, D. N.-Y., & Schmitt, C. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_4 · Cited by 14
Self-citationAnderson, G., Mackay, N. A., Gilroy, K. L., Hay, J., Borland, G., McDonald, A., Bell, M., Hassanudin, S. A., Cameron, E. R., Neil, J. C., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26443 · Cited by 14
The senescence pathway in prostatic carcinogenesis
Sharma, S., Shin, J., Grimshaw, M. J., Clarke, R. A., & Lee, C. S. (2010) · Pathology · doi:10.3109/00313025.2010.508791 · Cited by 14
New concept: cellular senescence in pathophysiology of cholangiocarcinoma
Sasaki, M., & Nakanuma, Y. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1133291 · Cited by 14
Zhang, S., Zheng, Y., Li, X., Zhang, S., Hu, H., & Kuang, W. (2023) · Aging · doi:10.18632/aging.204658 · Cited by 15
Regulation of cell function and identity by cellular senescence
Huna, A., Massemin, A., Makulyte, G., Flaman, J., Martin, N., & Bernard, D. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202401112 · Cited by 14
PPM1D activity promotes cellular transformation by preventing senescence and cell death
Stoyanov, M., Martinikova, A. S., Matějková, K., Horáčková, K., Zemánková, P., Burdová, K., Zemanová, Z., Kleiblová, P., Kleibl, Z., & Macůrek, L. (2024) · Oncogene · doi:10.1038/s41388-024-03149-3 · Cited by 14
Photoacoustic polydopamine-indocyanine green (PDA-ICG) nanoprobe for detection of senescent cells
Hartono, M., Baker, A. G., Else, T. R., Evtushenko, A. S., Bohndiek, S. E., Muñoz‐Espín, D., & Fruk, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-79667-7 · Cited by 16
Altered telomere homeostasis and resistance to skin carcinogenesis in Suv39h1 transgenic mice
Petti, E., Jordi, F., Buemi, V., Dinami, R., Benetti, R., Blasco, M. A., & Schoeftner, S. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1021517 · Cited by 16
Role of TWIST proteins in cancer progression
Bastid, J., Ciancia, C., Puisieux, A., & Ansieau, S. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44856 · Cited by 13
Gregorie, C. J., Wiesen, J. L., Magner, W. J., Lin, A. W., & Tomasi, T. B. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2009.02.009 · Cited by 13
Luo, H., Tao, C., Long, X., Huang, K., & Zhu, X. (2021) · Aging · doi:10.18632/aging.203146 · Cited by 17
NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04232-1 · Cited by 16
Molecular Mechanisms of Pituitary Adenoma Senescence
Chesnokova, V., Zonis, S., Ben-Shlomo, A., Wawrowsky, K., & Melmed, S. K. (2010) · Frontiers of hormone research · doi:10.1159/000318489 · Cited by 16
Hwang, H. J., Jung, S. H., Lee, H., Han, N. K., Bae, I. H., Lee, M., HAN, Y.-H., Kang, Y., LEE, S.-J., Park, H. J., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4473 · Cited by 14
Self-citationKim, W., Park, C., Park, J., Cheong, H., & Kim, S. (2020) · Food Science and Biotechnology · doi:10.1007/s10068-019-00730-5 · Cited by 13
Xie, B., Zhao, L., Chen, H., Jin, B., Mao, Z., & Yao, Z. (2013) · Biology of the Cell · doi:10.1111/boc.201200052 · Cited by 13
Injectable Senolytic Hydrogel Depot for the Clearance of Senescent Cells
Paganella, L. G., Bovone, G., Cuni, F., Labouesse, C., Cui, Y., Giampietro, C., & Tibbitt, M. W. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.4c00851 · Cited by 14
Wang, Z., Chen, C., Ai, J., Gao, Y., Wang, L., Xia, S., Jia, Y., & Qin, Y. (2025) · MedComm · doi:10.1002/mco2.70048 · Cited by 18
Cellular Senescence-Inducing Small Molecules for Cancer Treatment
Liu, P., Lu, Z., Wu, Y., Shang, D., Zhao, Z., Shen, Y., Zhang, Y., Zhu, F., Liu, H., & Tu, Z. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666180530092825 · Cited by 12
Streptonigrin at low concentration promotes heterochromatin formation
Loyola, A. C., Dao, K., Shang, R., Zhang, L., Dutta, P., Fowler, C. C., Li, J., & Li, W. X. (2020) · Scientific Reports · doi:10.1038/s41598-020-60469-6 · Cited by 12
Keeping your senescent cells under control
Zender, L., & Rudolph, K. L. (2009) · Aging · doi:10.18632/aging.100046 · Cited by 13
Spectral Karyotyping and Fluorescence In Situ Hybridization of Murine Cells
Rudolph, C., & Schlegelberger, B. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-409-4_30 · Cited by 12
Self-citationZhang, X., Guo, W., Wang, X., Liu, X., Huang, M., Gan, L., Cheng, Y., & Jin, L. (2016) · Oncotarget · doi:10.18632/oncotarget.8174 · Cited by 12
Why is PAK4 overexpressed in cancer?
Costa, T. D. F., & Strömblad, S. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106041 · Cited by 13
Oncogene-Induced Cellular Senescence: Causal Factor in the Growth Arrest of Pituitary Microadenomas?
Mooi, W. J. (2009) · Hormone Research in Paediatrics · doi:10.1159/000192442 · Cited by 14
Honoki, K., & Tsujiuchi, T. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2013.820010 · Cited by 13
Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention
Atkinson, S. P., & Keith, W. N. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000269 · Cited by 13
Senescence and Telomere Homeostasis Might Be Involved in Placenta Percreta—Preliminary Investigation
Geffen, K. T., Gal, H., Vainer, I., Markovitch, O., Amiel, A., Krizhanovsky, V., & Biron‐Shental, T. (2017) · Reproductive Sciences · doi:10.1177/1933719117737852 · Cited by 14
Tokmakov, A. A., & Sato, K. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.02.002 · Cited by 12
Pan, Y., Xu, H., Liu, R., & Jia, L. (2012) · Europe PMC (PubMed Central) · Cited by 16
TERRA beyond cancer: the biology of telomeric repeat‐containing RNAs in somatic and germ cells
Rivosecchi, J., & Cusanelli, E. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1224225 · Cited by 12
Yoshizaki, K., Fujiki, T., Tsunematsu, T., Yamashita, M., Udono, M., Shirahata, S., & Katakura, Y. (2009) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.80517 · Cited by 12
Vajen, B., Modlich, U., Schienke, A., Wolf, S. A., Skawran, B., Hofmann, W. A., Büsche, G., Kreipe, H. H., Baum, C., Santos‐Barriopedro, I., et al. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22040 · Cited by 12
Self-citationJehanno, C., Flouriot, G., Goff, P. L., & Michel, D. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.11.006 · Cited by 14
Histone methyltransferase SUV39H2 serves oncogenic roles in osteosarcoma
Piao, L., Yuan, X., Zhuang, M., Qiu, X., Xu, X., Kong, R., & Liu, Z. (2018) · Oncology Reports · doi:10.3892/or.2018.6843 · Cited by 13
Fan, Z., Li, L., Li, X., Zhang, M., Dou, M., Zhao, J., Cao, J., Deng, X., Zhang, M., Li, H., et al. (2019) · Aging · doi:10.18632/aging.101761 · Cited by 11
The potential of targeting Sin3B and its associated complexes for cancer therapy
Cantor, D. J., & David, G. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1386655 · Cited by 11
Shen, S., Passioura, T., Symonds, G. P., & Dolnikov, A. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.02.011 · Cited by 12
Abdelmoaty, A. A. A., Chen, J., Zhang, K., Wu, C., Li, Y., Li, P., & Xu, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1422363 · Cited by 11
Cancer stem cells: advances in biology and clinical translation—a Keystone Symposia report
Cable, J., Pei, D., Reid, L. M., Wang, X. W., Bhatia, S., Karras, P., Melenhorst, J. J., Grompe, M., Lathia, J. D., Song, E., et al. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14719 · Cited by 11
Self-citationShen, X., Wang, M., Chen, W., Xu, Y., Zhou, Q., Zhu, T., Wang, G., Cai, S., Han, Y., Xu, C., et al. (2023) · Aging · doi:10.18632/aging.204524 · Cited by 16
PROTAC as a novel anti-cancer strategy by targeting aging-related signaling
Peng, Y., Liu, D., Huang, D., Inuzuka, H., & Liu, J. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.09.004 · Cited by 10
Metadata
- Authors
- Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Medizinische Hochschule Hannover (DE)
- Research Institute of Molecular Pathology (AT)
- Max Delbrück Center (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2005-08
- Volume
- 436
- Issue
- 7051
- Pages
- 660-665
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2080769506
- Cited by
- 1,220
- References
- 31
- Citations by year
- 2026: 19 · 2025: 37 · 2024: 34 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 57 · 2019: 49 · 2018: 49 · 2017: 44 · 2016: 58 · 2015: 53 · 2014: 51 · 2013: 86 · 2012: 69
- FWCI
- 43.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cellular senescence, lymphoma, oncogenic Ras, SUV39H1, H3K9 methylation, heterochromatin, retinoblastoma pathway, p53, T-cell lymphoma, tumor suppression, epigenetic silencing, histone methyltransferase
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lymphoma, Methylation, Methyltransferases, Mice, Transgenic, Precancerous Conditions, Genes, ras, Repressor Proteins, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cellular Senescence, Apoptosis, Disease Progression, Transgenes, ADP-Ribosylation Factors, Chromosomal Instability, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.